These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26974491)

  • 21. Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C.
    Magdeleyns EJ; Keuren JF; Curvers J
    Transfusion; 2007 Oct; 47(10):1880-8. PubMed ID: 17880615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adults.
    Samama MM; Kunitada S; Oursin A; Depasse F; Heptinstall S
    Thromb Res; 2010 Oct; 126(4):e286-93. PubMed ID: 20807664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptidomimetic inhibitors for activated protein C: implications for hemophilia management.
    Butenas S; Orfeo T; Kalafatis M; Mann KG
    J Thromb Haemost; 2006 Nov; 4(11):2411-6. PubMed ID: 17059471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of endothelial cell-mediated generation of activated protein C by direct and antithrombin-dependent thrombin inhibitors.
    Linder R; Frebelius S; Jansson K; Swedenborg J
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):139-46. PubMed ID: 12632023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling of human factor Va inactivation by activated protein C.
    Bravo MC; Orfeo T; Mann KG; Everse SJ
    BMC Syst Biol; 2012 May; 6():45. PubMed ID: 22607732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
    Solymoss S; Nguyen KT
    Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma.
    Koestenberger M; Gallistl S; Muntean W; Leschnik B; Fritsch P; Cvirn G
    Thromb Haemost; 2005 Jul; 94(1):69-74. PubMed ID: 16113786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet factor 4 impairs the anticoagulant activity of activated protein C.
    Preston RJ; Tran S; Johnson JA; Ní Áinle F; Harmon S; White B; Smith OP; Jenkins PV; Dahlbäck B; O'Donnell JS
    J Biol Chem; 2009 Feb; 284(9):5869-75. PubMed ID: 19129181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
    Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
    Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of thrombin formation by active site mutated (S360A) activated protein C.
    Nicolaes GA; Bock PE; Segers K; Wildhagen KC; Dahlbäck B; Rosing J
    J Biol Chem; 2010 Jul; 285(30):22890-900. PubMed ID: 20484050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an inactivating cleavage site for alpha-thrombin on the heavy chain of factor Va.
    Erdogan E; Bukys MA; Orfeo T; Mann KG; Kalafatis M
    Thromb Haemost; 2007 Nov; 98(5):998-1006. PubMed ID: 18000604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
    Mosnier LO; Elisen MG; Bouma BN; Meijers JC
    Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
    Segers K; Dahlbäck B; Rosing J; Nicolaes GA
    J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation.
    Tanaka KA; Szlam F; Levy JH
    Br J Haematol; 2006 Jul; 134(1):77-82. PubMed ID: 16803571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF; Kalafatis M; Shatos M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
    De Smedt E; Wagenvoord R; Coen Hemker H
    Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.